CNS Pharmaceuticals, Inc. (CNSP) SEC filings
CNSP SEC filings moved a median of -3.16% by the close. CNSP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CNSP overview →
93 measured CNSP SEC filing events.
Where these CNSP SEC filings landedvs 92 measured CNSP SEC filing reactions
| Middle 50% of CNSP SEC filing reactions | -7.60% to +2.39% |
|---|---|
| Median reaction (to close) | -3.16% |
| Measured reactions | 92 |
Point-in-time · zero look-ahead
Half of the 92 CNSP SEC filing events with a measured close landed between -7.60% and +2.39%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K CNS Pharmaceuticals, For: Sep 30 | SEC filing · Form 8-K | — | +0.47% | |
| Form DEFA14A CNS Pharmaceuticals, | SEC filing · Form DEFA14A | — | -6.69% | |
| Form DEF 14A CNS Pharmaceuticals, For: Sep 30 | SEC filing · Form DEF | -0.76% | +4.03% | |
| Form 10-Q CNS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.02% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 02 | SEC filing · Form 8-K | +0.00% | +1.00% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | +2.07% | +6.00% | |
| Form D CNS Pharmaceuticals, | SEC filing · Form D | -1.61% | +2.41% | |
| Form S-3 CNS Pharmaceuticals, | SEC filing · Form S-3 | -1.61% | +2.41% | |
| Form 10-Q CNS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +1.32% | -5.47% | |
| Form 8-K CNS Pharmaceuticals, For: May 04 | SEC filing · Form 8-K | +5.89% | -14.50% | |
| Form 10-K/A CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.89% | +2.72% | |
| Form 10-K CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -7.84% | -15.10% | |
| Form 8-K CNS Pharmaceuticals, For: Mar 11 | SEC filing · Form 8-K | -4.75% | -17.32% | |
| Form 8-K CNS Pharmaceuticals, For: Feb 26 | SEC filing · Form 8-K | -0.64% | -3.49% | |
| Form S-8 CNS Pharmaceuticals, | SEC filing · Form S-8 | — | -1.88% | |
| Form 8-K CNS Pharmaceuticals, For: Feb 10 | SEC filing · Form 8-K | -5.88% | -4.12% | |
| Form 8-K CNS Pharmaceuticals, For: Dec 16 | SEC filing · Form 8-K | +1.48% | -5.25% | |
| Form 8-K CNS Pharmaceuticals, For: Nov 17 | SEC filing · Form 8-K | — | -1.58% | |
| Form 10-Q CNS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.15% | |
| Form DEFA14A CNS Pharmaceuticals, | SEC filing · Form DEFA14A | — | — | |
| Form ARS CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -3.47% | -6.82% | |
| Form DEF 14A CNS Pharmaceuticals, For: Nov 17 | SEC filing · Form DEF | +0.12% | +1.33% | |
| Form PRE 14A CNS Pharmaceuticals, For: Nov 17 | SEC filing · Form PRE | +1.08% | -5.13% | |
| Form 10-Q CNS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -19.33% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 17 | SEC filing · Form 8-K | +1.89% | -8.57% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 15 | SEC filing · Form 8-K | +2.55% | +0.61% | |
| Form 10-Q CNS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.48% | +5.79% | |
| Form 8-K CNS Pharmaceuticals, For: May 13 | SEC filing · Form 8-K | +3.64% | +14.54% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | -4.07% | -6.50% | |
| Form S-1/A CNS Pharmaceuticals, | SEC filing · Form S-1 | +1.80% | +9.01% | |
| Form 10-K/A CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -2.75% | -2.75% | |
| Form S-1 CNS Pharmaceuticals, | SEC filing · Form S-1 | +0.00% | -18.90% | |
| Form 8-K CNS Pharmaceuticals, For: Apr 09 | SEC filing · Form 8-K | -0.81% | +0.00% | |
| Form 10-K CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +8.06% | +2.38% | |
| Form 8-K CNS Pharmaceuticals, For: Mar 31 | SEC filing · Form 8-K | +8.06% | +2.38% | |
| Form 8-K CNS Pharmaceuticals, For: Mar 20 | SEC filing · Form 8-K | +3.19% | +7.85% | |
| Form 8-K CNS Pharmaceuticals, For: Feb 19 | SEC filing · Form 8-K | -5.18% | -12.20% | |
| Form 8-K CNS Pharmaceuticals, For: Jan 03 | SEC filing · Form 8-K | -2.20% | -20.80% | |
| Form 8-K CNS Pharmaceuticals, For: Dec 11 | SEC filing · Form 8-K | +0.28% | -1.47% | |
| Form 8-K CNS Pharmaceuticals, For: Nov 26 | SEC filing · Form 8-K | -3.83% | -7.67% | |
| Form DEFR14A CNS Pharmaceuticals, | SEC filing · Form DEFR14A | +7.84% | +16.17% | |
| Form 10-Q CNS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -2.95% | -11.38% | |
| Form 8-K CNS Pharmaceuticals, For: Oct 30 | SEC filing · Form 8-K | +10.08% | -6.17% | |
| Form DEF 14A CNS Pharmaceuticals, For: Nov 26 | SEC filing · Form DEF | +4.22% | +2.00% | |
| Form 8-K CNS Pharmaceuticals, For: Oct 23 | SEC filing · Form 8-K | -2.46% | -7.23% | |
| Form 8-K CNS Pharmaceuticals, For: Oct 23 | SEC filing · Form 8-K | +6.41% | -55.94% | |
| Form PRE 14A CNS Pharmaceuticals, For: Nov 26 | SEC filing · Form PRE | -0.01% | -0.81% | |
| Form 8-K CNS Pharmaceuticals, For: Sep 12 | SEC filing · Form 8-K | -2.85% | -5.27% | |
| Form 8-K CNS Pharmaceuticals, For: Sep 10 | SEC filing · Form 8-K | +2.19% | -6.88% | |
| Form 10-Q CNS Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +3.66% | +7.63% | |
| Form 8-K CNS Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | -5.87% | +6.61% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | -10.71% | -30.64% | |
| Form RW CNS Pharmaceuticals, | SEC filing · Form RW | +1.21% | -23.66% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 29 | SEC filing · Form 8-K | -10.29% | -51.59% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 30 | SEC filing · Form 8-K | +2.34% | -16.63% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 26 | SEC filing · Form 8-K | +1.51% | -3.60% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 19 | SEC filing · Form 8-K | -0.93% | +0.00% | |
| Form S-1/A CNS Pharmaceuticals, | SEC filing · Form S-1 | +1.91% | +0.95% | |
| Form 8-K/A CNS Pharmaceuticals, For: Jul 05 | SEC filing · Form 8-K | +1.22% | +4.24% | |
| Form S-1 CNS Pharmaceuticals, | SEC filing · Form S-1 | -5.00% | -1.67% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 05 | SEC filing · Form 8-K | -0.65% | -2.83% | |
| Form 8-K CNS Pharmaceuticals, For: Jul 03 | SEC filing · Form 8-K | -1.51% | -7.58% | |
| Form 8-K CNS Pharmaceuticals, For: Jun 26 | SEC filing · Form 8-K | +1.11% | -7.78% | |
| Form 8-K/A CNS Pharmaceuticals, For: Jun 14 | SEC filing · Form 8-K | +9.52% | -5.71% | |
| Form 8-K CNS Pharmaceuticals, For: Jun 14 | SEC filing · Form 8-K | +5.01% | -6.45% | |
| Form S-1 CNS Pharmaceuticals, | SEC filing · Form S-1 | +3.05% | +4.29% | |
| Form 8-K CNS Pharmaceuticals, For: Jun 03 | SEC filing · Form 8-K | -0.76% | +1.13% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | +2.86% | |
| Form 8-K CNS Pharmaceuticals, For: May 16 | SEC filing · Form 8-K | — | +6.29% | |
| Form 10-Q CNS Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +4.11% | +17.07% | |
| Form S-3 CNS Pharmaceuticals, | SEC filing · Form S-3 | -1.28% | -3.50% | |
| Form 8-K CNS Pharmaceuticals, For: May 06 | SEC filing · Form 8-K | +0.90% | +7.62% | |
| Form 8-K CNS Pharmaceuticals, For: Apr 30 | SEC filing · Form 8-K | +0.00% | -7.76% | |
| Form 8-K CNS Pharmaceuticals, For: Apr 09 | SEC filing · Form 8-K | -3.33% | -6.47% | |
| Form DEF 14A CNS Pharmaceuticals, For: Apr 30 | SEC filing · Form DEF | -5.13% | -2.60% | |
| Form 10-K CNS Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.25% | -14.58% | |
| Form 8-K CNS Pharmaceuticals, For: Apr 01 | SEC filing · Form 8-K | -1.25% | -14.58% | |
| Form PRE 14A CNS Pharmaceuticals, For: Apr 30 | SEC filing · Form PRE | -1.58% | -6.79% | |
| Form 8-K CNS Pharmaceuticals, For: Feb 21 | SEC filing · Form 8-K | -0.04% | -4.08% | |
| Form 8-K CNS Pharmaceuticals, For: Feb 14 | SEC filing · Form 8-K | -6.85% | -8.52% | |
| Form 8-K CNS Pharmaceuticals, For: Jan 29 | SEC filing · Form 8-K | +0.00% | +0.65% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | -1.93% | -11.11% | |
| Form 8-K CNS Pharmaceuticals, For: Jan 17 | SEC filing · Form 8-K | -0.04% | +0.00% | |
| Form S-1/A CNS Pharmaceuticals, | SEC filing · Form S-1 | +0.00% | -2.28% | |
| Form S-1/A CNS Pharmaceuticals, | SEC filing · Form S-1 | +0.94% | -4.72% | |
| Form 8-K CNS Pharmaceuticals, For: Dec 21 | SEC filing · Form 8-K | -0.33% | +10.38% | |
| Form 8-K CNS Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | -5.68% | -24.43% | |
| Form S-1 CNS Pharmaceuticals, | SEC filing · Form S-1 | +0.50% | -5.00% | |
| Form EFFECT CNS Pharmaceuticals, | SEC filing · Form EFFECT | — | +4.81% | |
| Form S-8 CNS Pharmaceuticals, | SEC filing · Form S-8 | -0.46% | +4.17% | |
| Form S-3 CNS Pharmaceuticals, | SEC filing · Form S-3 | +0.00% | -15.38% | |
| Form 8-K CNS Pharmaceuticals, For: Nov 15 | SEC filing · Form 8-K | +0.00% | +10.35% | |
| Form 10-Q CNS Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +10.35% |
Keep exploring
More CNSP: earnings → · analyst actions → · CNSP overview →